Managing the lipid triad: improving physicians' understanding of the role of omega-3 fatty acids with CME Submitted by amarin on Thu, 10/03/2019 - 20:42 Home Read more about Managing the lipid triad: improving physicians' understanding of the role of omega-3 fatty acids with CME
Comparison of atherosclerotic plaque characteristics among normal and high triglycerides (TGs) patients Submitted by amarin on Thu, 10/03/2019 - 20:02 Home Read more about Comparison of atherosclerotic plaque characteristics among normal and high triglycerides (TGs) patients
Predictive modeling to assess predictors of treatment success and failure among combination statin therapy patients Submitted by amarin on Thu, 10/03/2019 - 19:35 Home Read more about Predictive modeling to assess predictors of treatment success and failure among combination statin therapy patients
The potential of electronic health record data to optimize recruitment efficiency in cardiovascular outcome trials Submitted by amarin on Thu, 10/03/2019 - 19:33 Home Read more about The potential of electronic health record data to optimize recruitment efficiency in cardiovascular outcome trials
Eicosapentaenoic acid inhibits oxidation of small dense LDL in a manner distinct from related fatty acids in vitro Submitted by amarin on Thu, 10/03/2019 - 18:30 Home Read more about Eicosapentaenoic acid inhibits oxidation of small dense LDL in a manner distinct from related fatty acids in vitro
Eicosapentaenoic acid is a strong predictor of risk for heart failure in the multi-ethnic study of atherosclerosis Submitted by amarin on Thu, 10/03/2019 - 18:25 Home Read more about Eicosapentaenoic acid is a strong predictor of risk for heart failure in the multi-ethnic study of atherosclerosis
Effects of icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, on the fatty acid profile in plasma and red blood cells in statin-treated patients with persistent high triglycerides (results from the ANCHOR study) Submitted by amarin on Thu, 10/03/2019 - 16:59 Home Read more about Effects of icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, on the fatty acid profile in plasma and red blood cells in statin-treated patients with persistent high triglycerides (results from the ANCHOR study)
Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, placebo-controlled, Randomized, double-blind, 12-week study with an open-label Extension MARINE trial). Submitted by amarin on Mon, 09/30/2019 - 23:13 Home Read more about Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, placebo-controlled, Randomized, double-blind, 12-week study with an open-label Extension MARINE trial).
Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study) Submitted by amarin on Mon, 09/30/2019 - 23:09 Home Read more about Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Submitted by amarin on Mon, 09/30/2019 - 23:04 Home Read more about Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study).
